Cross breeding and molecular breeding companies are tackling climate change, hunger and crop resilience. Experts say choosing a patient investor is vital to fueling innovation.
Iron Road Partners' Emilie Abate shares her insights into what middle-market businesses and investors can expect from the SEC during Trump's second term